Invacare adds a range of specialist controls to its LiNX powerchair range

CARDIFF, United Kingdom, Aug-24-Aug-2017 — /EuropaWire/ — Global brand leader Invacare is once again raising the bar in the powerchair market, following on from the successful launch of the LiNX control system last year. Invacare has taken the smart technology a step further with a new touch screen remote, in-built Bluetooth technology, enhanced programming features and a range of specialist controls, all available on the remarkable Invacare LiNX powerchair range.

Touch screen remote
Introducing next generation technology to powerchairs, Invacare is pleased to present the REM400 remote with its 3.5” interactive screen that requires minimal force to operate. Following extensive customer-insight research, this innovative remote can be configured to a users’ physical and cognitive ability, thanks to its extensive functional capabilities. Also available is a REM500, a display only version of the REM400. Both remotes can be used with a wide range of specialist controls.

Bluetooth technology
The REM400 and REM500 controls have built-in Bluetooth technology to allow users to connect to their PC, Mac and compatible Android devices that have built-in HID functionality.

Enhanced programming features
The LiNX system now allows professionals to mix and match the drive, seating and environmental controls in order to customise the display to suit the user’s lifestyle. E.g. The profiles can be customised by names such as Home, Outdoor and Work, with functions specific to each one. Profiles can also be set by user input options i.e. head control.

Another new feature is the ability to adjust the joystick commands. The basic commands on a powerchair are forward, reverse, left and right but there are also other commands such as tilt, recline, lights, horns etc. to consider. The REM400 and REM500 allow these commands to be changed to suit the user, based on frequency or even by accessibility.

Specialist controls
To maximise a user’s control and independence, the REM400 and REM500 allow a selection of specialist user inputs to be used on Invacare’s remarkable powerchairs. They range from head controls, chin controls, Sip ‘n’ puff systems, joystick options, proximity switches and dual controls, allowing Invacare to provide a control solution for many powerchair users. To help professionals select the best control for a powerchair user, Invacare has put together a useful app with five simple steps to assist with the process. Take a look at the app by visiting www.linx4you.com plus it can downloaded from the Google Play Store and Apple App Store.

TDX SP2 base updates
The above offering is available on all Invacare LiNX powerchairs, with a selection of the specialist controls only compatible with the TDX SP2 Ultra Low Maxx – and it is with this chair that Invacare is now able to fully enter the complex rehab market. For more information on the TDX SP2 Ultra Low Maxx, visit www.invacareULM.com. As well as feature heavy, the TDX SP2 base itself can be customised thanks to the 10 contemporary shroud and rim insert options available which sit nicely on its new black tyres and castors. There is a new single sided fork option on the front and rear castors.

SOURCE: EuropaWire

Connect. Integrate. Become One.

International Day of Yoga 21 June

Alpharetta, Georgia, US, 2017-Jun-13 — /EPR HEALTHCARE NEWS/ — The Heartfulness Institute will mark the International Day of Yoga on 21 June with public events in various locations globally (www.heartfulness.org). The events will be held at the Institute’s meditation and retreat centres and also at other community venues in partnership with civil society and yoga organizations and Indian diplomatic missions.

Every year on 21 June the United Nations invites the global community to celebrate the life-enhancing practices of Yoga. In establishing the International Day of Yoga, the United Nations underscored the need for building better lifestyles, recognizing that Yoga provides a holistic approach to health and well-being. The UN also called for the wider dissemination of information about the benefits of practising Yoga.

On the International Day of Yoga, the Heartfulness community, led by its youth, will bring together hundreds of thousands of people with the theme ‘Connect. Integrate. Become One’, in Chennai, Singapore, Hyderabad, Paris, New York, London, Toronto, Sydney and in other major metropolitan centres, as well as in many smaller cities, towns and rural areas globally. The core practices of Heartfulness are self-development tools for a modern lifestyle and for people from all walks of life. They include relaxation, heart-based meditation, cleaning and inner connection. There is no dogma or prerequisite of any kind, and no financial requirement; only the willingness and interest to try the simple, effective Heartfulness practices.

Since the beginning of 2017, the Heartfulness Institute has been offering free masterclasses in meditation, led by its global guide, Kamlesh Patel, also known as Daaji. More than one million people around the world, including educational, business and professional groups, have experienced the free masterclasses that are available at http://en.heartfulness.org/masterclass/.

Heartfulness is an approach to the Raja Yoga system of meditation called Sahaj Marg, founded at the turn of the 20th century and formalized into an organization in 1945. More than seventy years later, ongoing Heartfulness meditation training can be found at 2,500 schools and colleges, and over 100,000 professionals are meditating in over 3,000 corporations, non-governmental and government organizations.

Heartfulness Centres, known as HeartSpots, exist in 130 countries, supported by thousands of certified volunteer trainers. There are over 5,000 HeartSpots and over 300 retreat centres around the world where thousands of people gather to meditate (http://www.heartfulness.org/).

About Kamlesh D. Patel
Known to many as Daaji, Kamlesh D. Patel is the fourth guide in the Heartfulness tradition of meditation. He is a prolific speaker and writer, and you can read his latest writings at http://www.daaji.org/.

About Heartfulness Institute
Heartfulness Institute is a non-profit organization that promotes well-being and self-development through meditation, research and training. The Institute offers programs for individuals, local communities, corporates, government departments and the armed services, schools and colleges, rural communities and civil society groups worldwide, supported by certified trainers who are volunteers and who offer their time and expertise in this social cause.

For more information 
Email: info@heartfulness.org
Toll free numbers:India: 1-800-103-7726USA: 1-844-879-4327
Social Media: Heartfulness Facebook | Twitter | Google+ | YouTube | LinkedIN | Instagram

Websites: www.heartfulness.org, www.daaji.org
Durga Nagarajan, 180 Westchester Way, Alpharetta,Georgia 30005

Via EPR Network
More Healthcare press releases

MEDLAB Series Europe, 13-15 Sep 2017, will cover Point of Care Testing (POCT), Histopathology, Lab Management, Microbiology and Haematology

Spain, 04-May-2017 — /EuropaWire/ — After many years of operating successful MEDLAB events around Africa, Asia and the Middle East, Informa Life Sciences Exhibitions, the worlds leading publishing and exhibitions company, has announced that the MEDLAB Series will be expanding its presence into Europe. Taking place at the Barcelona Congress Centre in Barcelona, Spain, from 13-15 September 2017, more than 3,000 industry professionals are expected to attend Europe’s leading event for laboratory management and diagnosis.

With the European In-Vitro Diagnostics (IVD) market expected to reach USD 15.5 billion by 2024, a platform such as MEDLAB presents a huge opportunity for global laboratory industry leaders, including manufacturers, dealers and distributors, to make inroads into the European market. Housing international exhibitors and covering 2,000 sqm of exhibition space, MEDLAB Europe will give visitors from across the world an opportunity to access cutting-edge laboratory products, next-generation technology, innovative services and world-class educational content.

According to Tom Coleman, Group Exhibition Director, MEDLAB Series: “The launch of MEDLAB Europe is in line with our global expansion strategy for our MEDLAB series of events. The increasing prevalence of chronic diseases, rising geriatric population coupled with the rising awareness towards early diagnosis, has positioned the European IVD and medical laboratory market as a critical market for manufacturers, services providers, and dealers and distributors from across the globe. MEDLAB Europe will generate substantial value for our customers and partners by driving further product innovation and deeper engagement in these specific markets.”

Over the four-day event, MEDLAB Europe will also offer a multi-disciplinary congress tackling current challenges and developments key to the European market, and leveraging the true potential of laboratory testing to dramatically improve patient outcomes across the continent.

The conference programme covers five main tracks including Point of Care Testing (POCT), Histopathology, Lab Management, Microbiology and Haematology. From new methods of effective lab management to the development of techniques in detecting diseases, the conferences will also review the expanding role of the laboratory medicine and discuss partnership between a clinician and a lab professional in providing delivery of care to every patient.

“The scientific programme at MEDLAB has been carefully designed in collaboration with some of the brightest minds in the medical laboratory industry in order to have a real impact on improving the health and wellbeing of patients across the region,” said Coleman.

For more information about the MEDLAB Europe Exhibition & Congress, please visit: www.medlabeurope.com.

SOURCE: EuropaWire

Multispectral Optoacoustic Tomography (MSOT) can now more reliably detect early stages of inflammation

GERMANY, Mar-30-2017 — /EPR HEALTHCARE NEWS/ — Ulcerative colitis and Crohn’s disease are the most common inflammatory bowel diseases (IBD). Globally, more than 4 million people suffer from recurring inflammation of the intestinal mucosa. To date, non-invasive methods have not been able to detect these forms of IBD reliably. Researchers at the University Hospital Erlangen (Germany) have now shown for the first time how Multispectral Optoacoustic Tomography (MSOT) can more reliably detect early stages of inflammation when compared with other non-invasive diagnostic methods. These results have recently been published in the New England Journal of Medicine.

Evaluating the inflammatory activity of the intestines early and accurately helps to prevent complications associated with IBD and guide an optimal therapy regime. Currently, doctors frequently rely on an invasive endoscopy procedure to assess the intestinal mucosa of patients with IBD. Additionally, non-invasive imaging methods are increasingly used in the clinic. For example, ultrasound allows clinicians to examine the structure, thickness and blood perfusion of the intestinal wall with changes in perfusion patterns indicating an onset of inflammation.

“With the MSOT procedure, we additionally use laser light, by which we can detect inflammation earlier than previously possible with ultrasound”, explains Prof. Dr. Maximilian Waldner, Professor at the University Hospital Erlangen. “The earlier we detect signs of an upcoming flare – i.e., a change in blood content – the quicker we can react and start a preventive treatment”. The MSOT technology was developed by iThera Medical in Munich, and was first used on IBD patients last year.

The researchers of the University Hospital Erlangen have recently published their results in the renowned New England Journal of Medicine. “We examined 108 patients with Crohn’s disease using the MSOT technology and compared the results to established non-invasive diagnostic procedures as well as endoscopy and histology”, says Prof. Waldner. “We were able to demonstrate that hemoglobin values in the tissue measured with MSOT indicate very accurately the inflammatory activity in the intestines. The method appears to be superior to other non-invasive procedures, as MSOT for the first time was able to detect even low levels of inflammation without having to perform endoscopy”.

Dr. Ferdinand Knieling, a physician at the University Hospital Erlangen, adds: “We are hoping that this principle can be applied to many applications and, in particular, also be used to enable safe evaluations of children and adolescents. With this new examination method, many of the currently invasive procedures might become obsolete.”

In optoacoustic imaging, the physician scans the intestines transabdominally through the skin, applying pulsed laser light in the near-infrared region. The energy of the light absorbed in tissue is converted into acoustic signals which are then acquired by an ultrasound detector. Christian Wiest, CEO of iThera Medical, comments: “MSOT is a new diagnostic imaging modality that can detect changes in tissue composition associated with a variety of diseases, without the use of contrast agents. The technology has already been applied in other clinical feasibility studies, e.g. for the detection of melanoma metastasis in sentinel lymph nodes or for the assessment of suspicious breast lesions”.

The results of the IBD study at the University Hospital Erlangen were published on March 30th 2017 in the New England Journal of Medicine (Volume 376, Issue 13, pg.1292-1294).

SOURCE: EuropaWire

Cambridge Micelle Technology in Carocelle® Lycopene and Resveratrol anti-ageing and cardio-protective formula

Cambridge, England, 2017-Feb-14 — /EPR HEALTHCARE NEWS/ — Resveratrol and lycopene are the compounds known for anti-ageing and cardio-protective properties. Mediterranean diet based, among others, on consumption of big quantities of lycopene-rich vegetables coincides with a longer lifespan, lower incidence of CVDs and reduced occurrence of some forms of cancer among the population of Mediterranean region. High resveratrol consumption is considered a factor in “French Paradox”, where epidemiological data show low incidence of CVDs, despite high consumption of saturated fats. Consumers have enormous choice of food supplements including lycopene and resveratrol, but key information is often missing: what happens to the substance once consumed and how much of it is really absorbed?

Resveratrol – the powerful anti-ageing, antioxidant polyphenol

Resveratrol is a phytochemical from polyphenols family, compounds known for their antioxidant properties. It is produced by plants in response to different stresses from their surrounding environment and found mainly in the peel and seeds of red grapes, also in peanuts and berries. High resveratrol consumption is considered a factor in “French Paradox”, where epidemiological data show apparent disconnect between the incidence of cardiovascular diseases in French population and high consumption of saturated fats. It is thought to be related to high consumption of red wine that contains resveratrol. There is significant scientific research on the beneficial effects of resveratrol relating to anti-ageing and longevity – activation of sirtuin enzymes, support of mitochondrial metabolism, protection of telomeres, antioxidant properties. It also supports cardiovascular health and influences glucose metabolism management.

Lycopene – great contributor to healthy skin

Lycopene belongs to family of plant-derived substances – carotenoids. Due to their strong antioxidative properties carotenoids help protect plants from oxidative damage caused by various stressing factors. Scientific interest in lycopene originates from the phenomenon of the Mediterranean diet and its’ cardio-protective and longevity promoting properties. The Mediterranean diet is based, among others, on high consumption of tomatoes and other vegetables that contain high levels of lycopene and other carotenoids. The population of the Mediterranean region has a longer lifespan, lower incidence of cardiovascular diseases and lower occurrence of some forms of cancer. Because of its’ antioxidative properties lycopene helps fight against free radicals in the skin, reduces its’ sensitivity to UV radiation, reduces mitochondrial DNA damage, lowers the risk of heart diseases.

Carocelle® presents best in class lycopene and resveratrol anti-ageing supplement

The main challenge of resveratrol supplementation remains its’ bioavailability. As quickly as it is absorbed from intestinal tract to bloodstream most of it is transformed into inactive compounds. New Carocelle® Lycopene & Resveratrol formulation delivers superior bioavailability, proven in clinical trials. Carocelle® technology makes resveratrol over +500% more bioavailable than other products on the market and provides its’ outstanding concentration that would normally be difficult to obtain from other available sources.

Pharmacokinetic tests for Carocelle® Lycopene have also confirmed 2x higher concentration of lycopene in the bloodstream (bioavailability) in comparison to reference brand available on the market, with the same dosage of the compound.

Carocelle® Technology behind compounds’ superior bioavailability

Vesicle-micellisation helps carotenoids become more resistant to degradation in the highly acidic stomach environment. This ensures that more active lycopene and resveratrol can pass to the intestines and be absorbed. The vesicle-micelle format is easily transformed in the intestines by bile acids to the mixed micelles. This guarantees optimal absorption of fat-soluble ingredients, like lycopene and resveratrol. The result is increased delivery of active lycopene and resveratrol to the intestine for maximum absorption, improved bioavailability and remarkable bioactivity. Chaperone compounds in Carocelle® Lycopene & Resveratrol vesicle-micelles additionally contribute to increased bioavailability of both lycopene and resveratrol.

There are currently 3 SKUs within Carocelle® range:

Carocelle® Lycopene & Resveratrol
Carocelle® Lutein & Zeaxanthin
Carocelle® Lycopene

For more information please visit www.carocelle-technology.com or contact us at contact@carocelle-technology.com

COMPANY PROFILE
Carocelle Cambridge Micelle Technologyâ„¢ was founded in 2015 in collaboration with UK biotech firm Lycotec, headed by Dr. Ivan Petyaev. The company invents proprietary formulations and products that are scientifically tested and proven in laboratories in Cambridge, UK. Carocelle Cambridge Micelle Technologyâ„¢ has its headquarters in Cambridge and operates a network of partnerships with research and commercial partners around the world.

DR. IVAN MIKHAILOVICH PETYAEV, MD, PHD
Dr. Petyaev is a medical doctor, researcher and author of scientific publications and inventions with applications in diagnostics, analytics, prevention and treatment of a variety of diseases. He spent his research years at MRS and Cambridge University in the Department of Pathology. To take his discoveries into innovative healthcare products he left University and set up his own company, Lycotec Limited. Dr Petyaev has wide experience of driving his innovations through the product development phase, clinical validation and in the setting up of industrial production of the successful prototypes. His projects have been supported by Cambridge University, the MRC, Papworth and Addenbrooke’s Hospitals, the British Heart Foundation, the Department for Trade and Industry and the Eurostars Eurica Project.

Via EPR Network
More Healthcare press releases

Five Years After Iraq War’s Official End, a New York Community Is Still Healing

NEW YORK, NY, 2017-Jan-14 — /EPR HEALTHCARE NEWS/ — As the Iraq War’s official end in December 2011 marks its fifth anniversary, many questions remain on its fallouts. New York’s French-American community is one of them, as it remembers its blacklisting when France opted out of attacking Iraq.

Choosing diplomatic pressure rather than “shock and awe” ignited fury for many in New York. The call for anti-French boycotts resonated in tabloids as pictures of New Yorkers spilling wines in gutters vied with accusations of an ally’s betrayal and cowardice. Information can be found by searching for “New York’s anti-French boycotts and Iraq,” and “Freedom fries.”

How effective were the boycotts? “Very much so, even devastating,” says French consulate’s official physician and mental health coordinator at the time, Gérard Sunnen, MD, “the French-American community of New York was stunned by their virulence and persistence. Why, many wondered, did they materialize only in New York, in striking contrast to the rest of the country?”

“Targeted were all manner of French-American businesses, from Air France to bakeries, as rosters of marked companies circulated widely. Earliest felled were restaurants, whose sales plummeted by as much as half. Like dominoes, they closed their doors, dismissing their workers. Called by many the “consulate’s darkest hour,” it went on for interminable months, years, and still resonates today.”

“As layoffs mounted,” Dr. Sunnen added, “so did their mental health consequences, from all manner of stress reactions to self-destructive depressions. And workers suddenly out of work could not find employment because no one would take them. The consulate’s social services department work load soared to levels never attained before.”

Faced with this onslaught, the New York State Department of Health (NYSDOH) was repeatedly contacted to lend the community its medical and mental health assistance. In addition, New York State and city top officials were insistently asked to add their voice to call off the boycotts. All appeals remained unanswered and, for reasons of non-assistance and abandonment of responsibility, this matter was eventually reported and filed in New York and Federal courts.

Dr. Sunnen, who also cites his experience as a Vietnam-era U.S. veteran, concludes, “history needs constant reckoning, otherwise it can remain a fable. These events are now brought to light so that long-term allies can better understand and appreciate the meaning of their special relationship.”

References:

Gérard Sunnen, MD, www.triroc.com/sunnen
Supreme Court, State of New York, No. 102194/2012
U.S. District Court, Southern District of NY 12 Civ. 3417
U.S. Court of Appeals, 2nd Circuit 13-465cv
U.S. Health and Human Services (HHS) 1:13-cv-1242
New York State Division of Human Rights (NYSDHR) No. 10181422
National Transportation Safety Board (NTSB) No. DCA96MA070

Contact-Details: Gerard Sunnen, MD
gsunnen@aol.com
www.triroc.com/sunnen

Via EPR Network
More Healthcare press releases

New York’s Health Agency (NYSDOH) Cited in Iraq War’s Blowback

New York, NY, 2016-Dec-31 — /EPR HEALTHCARE NEWS/ — As the Iraq War’s official end on December 18, 2011 marks its fifth anniversary, many questions remain on its fallouts. New York’s French-American community is one of them, as it remembers its blacklisting when France opted out of attacking Iraq.

Choosing diplomatic pressure rather than “shock and awe” ignited fury for many in New York. The call for anti-French boycotts resonated in tabloids as pictures of New Yorkers spilling wines in gutters vied with accusations of an ally’s betrayal and cowardice. Information can be found by googling “New York’s French boycotts and Iraq,” and “Freedom fries.”

How effective were the boycotts? “Very much so, even devastating,” says French consulate’s official physician and mental health coordinator at the time, Gérard Sunnen, MD, “the French-American community of New York was stunned by their virulence. Why, many wondered, did they materialize only in New York, in striking contrast to the rest of the country?”

“Targeted were all manner of French-American businesses, from Air France to bakeries, as rosters of marked companies circulated widely. Earliest felled were restaurants, whose sales plummeted by as much as half. Like dominoes, they closed their doors, dismissing their workers. Called by many the “consulate’s darkest hour,” it went on for weeks, interminable months, and still resonates today.”

“As layoffs mounted,” Dr. Sunnen added, “so did their mental health consequences, from all manner of stress reactions to self-destructive depressions. And workers suddenly out of work could not find employment because no one would take them. The consulate’s social services department work load soared to levels never attained before.”

Faced with this onslaught, the New York State Department of Health (NYSDOH) was repeatedly contacted to lend the community its medical and mental health assistance. In addition, New York state and city top officials were insistently asked to add their voice to call off the boycotts. All appeals remained unanswered and, for reasons of non-assistance and abandonment of responsibility, this matter was eventually reported and filed in New York and Federal courts.

Dr. Sunnen, who also cites his experience as a Vietnam-era U.S. veteran, concludes, “history needs constant reckoning, otherwise it can remain a fable. These events are now brought to light so that long-term allies can better understand the meaning of their relationship.”

References:

Gérard Sunnen, MD: www.triroc.com/sunnen
Supreme Court, State of New York, No. 102194/2012
U.S. District Court, Southern District of NY 12 Civ. 3417
U.S. Court of Appeals, 2nd Circuit 13-465cv
U.S. Health and Human Services (HHS) 1:13-cv-1242
New York State Division of Human Rights (NYSDHR) No. 10181422
National Transportation Safety Board (NTSB) No. DCA96MA070

Contact-Details: Gerard Sunnen, MD

Via EPR Network
More Healthcare press releases

Startup mentored by Promwad created one of the best IoT products in Europe

Vilnius/Lithuania, 2016-Oct-18 — /EPR Healthcare News/ — ZIVE smart radiation monitor has reached the final of Elektra Awards 2016, a big influential contest for the electronics market players. This device designed by R-NOX startup with the assistance of Promwad Electronics Design House was named one of six best innovative products of Europe exploiting the Internet of Things potentialities.

ZIVE is a portable radiation monitor of the next generation that can connect to smartphones and tablets via Bluetooth. It’s the first device of professional level designed for common people. It has a user-friendly interface, a Geiger-Muller counter, and a low market price comparing with other high-precision radiation monitors.

promwad-mobile_zive

ZIVE radiation monitor measures gamma rays, ionizing radiation, and X-rays. Differentiating features of the device:

  • Calibrated by accredited European laboratories (CE).
  • High accuracy at a lower price in comparison with other similar devices.
  • “Smart monitor” mode that provides users with specific health and well-being advice: how to interpret the measurements and reduce the risks.
  • Working with maps to create eco-routes: save radiation spots, find cleaner routes.

The collected ZIVE data is used for the real-time global map of radiation contamination.

Roman Pakholkov, Promwad’s CEO and R-NOX’s mentor, says that the data collected by ZIVE users is stored in the eco-platform, which is becoming the most detailed in the world. This platform allows accelerating the innovations development for the environmental management and can be integrated into other devices and applications via the open API.

To date, R-NOX has developed partnerships with the largest tour operator in the Chernobyl Nuclear Power Plant Zone of Alienation; Greenpeace; companies and organizations in Japan, Finland, Singapore, and other countries.

Promwad continues its work in supporting new electronics design projects in the IoT field. The company believes in the high potential of this popular trend and are ready to share their experience in the development and manufacture of electronic products for the global consumer electronics market.

The best companies of Elektra Awards 2016 will be announced on Thursday, 1st December, at the awards ceremony taking place in The Ballroom, Grosvenor House Hotel, London.

Contact-Details:
promwad-logo
Promwad

Olga Potonya
olga.potonya@promwad.com
+370 (5) 214 12 44 ex.227

Via EPR Network
More Healthcare press releases

Global leader in serialization solutions Systech to attend the annual pharmaceutical congress CPhI Worldwide in Barcelona, 4 – 6 Oct 2016

systech_international_slogo_europawireBRUSSELS, 28-Sep-2016 — /EuropaWire/ — Systech International, a global leader in brand protection technologies, will partner with Sharp Packaging and SINEL SYSTEMS, part of the Autajon Group, at CPhI Worldwide, the annual pharmaceutical congress held in Barcelona from 4 – 6 October 2016.

Systech will be part of Sharp’s panel discussion addressing delegates on the theme of “Serialization: Optimizing Your Supply Chain Means Optimizing Your Partners.” The presentation will explore the critical path to supply chain readiness, risk assessment, benchmarking and serialization risk mitigation options. The briefing will take place in the Pharma Insight Briefing room on Tuesday, 4 October 2016 at 11:30am CEST.

Systech will also showcase its UniSeries™ serialization software offered as an integrated solution within Autajon’s exhibit booth #2P16 (Hall 2).

CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, will host more than 36,000 visiting pharma professionals from 4-6 October at the Fira Gran Via, Barcelona, Spain. More than 2,500 exhibitors from 150+ countries gather at the event to network and take advantage of more than 100 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in a new location in Barcelona.

With thousands of implementations across the globe, Systech is the world’s most trusted brand protection expert, and its UniSeries offering is the industry standard for serializing products. UniSeries is offered as an integrated solution with both Sharp Packaging and Autajon Group’s hardware. Systech’s patented, configurable software offers manufacturers the flexibility to adapt to new regulations without extensive reworking or revalidation, thereby reducing implementation, training and support costs.

“We are recognized as the world leader in serialization and brand protection,” states Manfred Voglmaier, Senior Director Sales Europe, Systech International. “With more than 30 years of experience in providing highly configurable solutions for serialization across a variety of industries ― along with our partners Sharp Packaging and Sinel ― gives us a unique insight for this panel.”

Systech’s products are in greater demand than ever before since it is estimated that over 15,000 production lines for prescription medication in Europe must be fitted with a serialization system over the next three years. The European Commission adopted a regulation on October 2, 2015, under which the serialization of prescription medicine packages will become mandatory in all EU countries by 2019.

Show exhibit hours are on Tuesday, 4 October – Thursday, 6 October. Systech representatives will be available in the Sharp Packaging booth #3L56 (Hall 3) during the event, as well as in the Autajon booth #2P16 (Hall 2). They will showcase Systech’s software solutions on sample packaging lines and via live demos throughout the event.

SOURCE: EuropaWire

Finnish Servicepoint to resell, install and support Systech’s serialization solutions in Scandinavia, the Baltic States, and Russia

servicepoint-fi__logo_europawireFinland, 23-Sep-2016 — /EPR HEALTHCARE NEWS/ — Systech International, a global leader in brand protection technologies, today announces the extension of its strategic partnership with Servicepoint, a leading serialization automation supplier.

Systech has signed a global agreement with Servicepoint, allowing the company to act as a single point of contact for customers across Europe. Through this agreement, Servicepoint will now resell, install and support Systech’s serialization solutions to customers of any size across Europe, especially in Scandinavia, the Baltic States, and Russia.

This agreement comes at a critical time within the pharmaceutical industry, as the European market is growing exponentially. It is estimated that over the next three years, 15,000 production lines for prescription medication in Europe must be fitted with a serialization system. The European Commission adopted a regulation on October 2, 2015, under which the serialization of prescription medicine packages will become mandatory in all EU countries by 2019.

Systech and Servicepoint first engaged two years ago when jointly delivering serialization and automation/integration solutions to a pharmaceutical manufacturing client. As a result, both companies were able to offer enhanced solutions and increase their speed of delivery.

Servicepoint maintains and offers professional services, automation services, retrofit/upgrade services to Systech customers and provides Level 1 and 2 support, while Systech provides Level 3 support for the software.

“Servicepoint has a solid network of over 50 professionals in Europe, which, when combined with Systech’s growing regional support, creates a large and experienced talent pool for the delivery of serialization initiatives,” states Harry Saint-Preux, Director, Global Alliances & Channels, Systech International.

“Servicepoint has extensive expertise and a long history automating hundreds of production lines for different fields of industry and European pharmaceutical manufacturers, as well as experience with track-and-trace initiatives. Systech and Servicepoint’s combined approach provides manufacturers with the solutions, services and support required to address Europe’s challenging serialization requirements,” notes Saint-Preux.

Risto Finne, chairman of the board, Servicepoint, comments, “Servicepoint is honored to enter into this partner agreement with Systech, who we consider to be the global market leader in serialization. This cooperative paves the way for numerous new business opportunities, particularly with Russian companies that need to rapidly employ serialization. Our experience in integrating modifications and upgrades of existing production lines, in addition to new, turnkey, fully-automated solutions for the serialization and packing of medical, food and other sensitive products puts us in an enviable market position.”

Servicepoint is one of only a handful of suppliers in the European market that provides an all-inclusive production automation solution including planning, installation, testing, and maintenance.

SOURCE: EuropaWire

Sway Medical’s app for sports concussion exam received European CE Mark as Medical Device

sway-concussiontest-is-a-validated-ios-app-based-concussion-management-system

TULSA, OK, 08-Sep-2016 — /EPR HEALTHCARE NEWS/ — Sway Medical is a US medical device company who’s software turns an iPhone or iPad into a mobile medical device that provides immediate medical grade, objective concussion measurement to medical professionals.

Sway Medical LLC (Sway) would like to announce its official availability in all European Union Countries. Sway was issued its CE Mark after being marketed in the United States and Canada for two years. This is significant because European sports organizations ranging from youth through pro level now have an affordable and convenient sideline assessment tool supporting concussion related medical decision making. Medical professionals and trained coaches can obtain a concussion assessment via an Apple mobile device (iPhone or iPad) and the Sway Balanceâ„¢ System web-portal. Acute objective measurements are obtained by performing a 1.5 minute balance and reaction time test protocol. Licensed athletic trainers, physical therapists and athletic therapists are able to join physicians in acutely managing the underserved market of youth sports, ages six and older.

Concussion injuries are very common in sports, often going un-reported or ignored until the obvious symptoms have incapacitated the athlete or draws the attention of a parent or coach. Second Impact Syndrome (SIS) is a serious medical condition with published mortality rates of up to 50%. SIS occurs when an athlete returns to play while still recovering from an initial concussion injury. During this time, the brain is highly susceptible to additional injury and complications. The Sway Balance™ System is able to accurately assess and track the acute and chronic outcome related to an athlete’s balance, motion reaction time and concussion symptoms. The Sway Balance™ System provides a graphical representation comparing suspicious injury event tests against a pre-injury “normative” or baseline score. The comparison of event tests against an established baseline is a common measurement for traumatic brain injury diagnosis and recovery tracking.

The Sway Balance™ System is available for purchase by licensed medical professionals involved in school, occupational or sports medicine through www.swaymedical.com. Additional protocols are available to assess an individual’s “Fall Risk” or “Functional Status”.

SOURCE: EuropaWire

Women Grow, Sonoma County Celebrates 1-Year Anniversary

Join The Anniversary Celebration of the Fastest-Growing Organization In The Cannabis Industry

Santa Rosa, CA, 2016-Jun-17 — /EPR HEALTHCARE NEWS/ — It has been 20 years since California pioneered the nation in legalizing medical cannabis with Prop 215. Now California makes up 49 percent of the nation’s robust cannabis economy. California’s cannabis scene has exploded like the Wild West and there’s one more reason to celebrate. Sonoma County’s Canna-enthusiasts are invited to join Women Grow to mark its 1-year Anniversary with a celebration and award ceremony to honor ‘The Godmother of Cannabis’, Lynnette Shaw.

Women Grow is a national organization that seeks to connect and empower women in the legal cannabis industry and the group’s Sonoma County Chapter is excited to share their achievements. In the past year, the Chapter brought in 23 industry leader speakers and panelists, of whom 21 were women and 2 were men. Speakers have included: Amanda Reiman, Manager of Marijuana Law and Policy at Drug Policy Alliance, Samantha Miller, President and Chief Scientist at Pure Analytics, Ellen Komp, Deputy Director at California NORML and Jazmin Hupp Co-Founder/CEO of Women Grow.

“The cannabis industry’s future is held in our hands,” says Chapter Founder and Chairwoman, Ilana ‘Sugar’ Laytart. “We are currently writing the history and HER-story books and this event’s celebration is to acknowledge our commitment and perseverance in this movement.”

The celebration takes place on Thursday, July 7, from 6pm to 10pm at Annie O’s Music Hall in downtown Santa Rosa. “Celebration Attire” is suggested. Early-bird tickets cost $25 and can be purchased through Universe.com.

women grow

When: Thursday, July 7th, 6pm-10pm
Where: Annie O’s, 120 5th Street, Santa Rosa
Cost: EARLY BIRD $25
REGULAR $35
DOOR $40 CASH ONLY
Event Highlights:
Terpenes 101 + Aroma Bar Presentation with Monica Fine of Absorb CBD and The Seasonal Apothecary.
Award Ceremony Honoring Lynnette Shaw, presented by Ilana ‘Sugar’ Laytart and Elaine Holtz.
Dessert Bar, DJs & Dancing, Giveaways, Snacks & Beverages and Cash Bar

Interested in being a sponsor? Email sonomacounty@womengrow.com

Purchase Advance Tickets here: https://www.universe.com/women-grow-sonoma

Financial assistance may be available. Email sonomacounty@womengrow.com to inquire.

This is a 21+ event and a non-consumption event.

****
Women Grow connects, educates, inspires and empowers the next generation of cannabis industry leaders by creating programs, community and events for aspiring and current business executives in the cannabis industry. Women Grow is the fastest “growing” network of female-forward cannabis businesses and the largest networking organization in the cannabis industry. You don’t have to be a current professional in the cannabis industry to join. The Sonoma County Chapter is run by Founder and Chairwoman Ilana ‘Sugar’ Laytart and Co-Chair: Joyce Williams.

While events are women focused, their networking series welcome and attracts both men and women to connect. Women Grow Networking Events occur the first Thursday of every month in Sonoma County. Website: www.womengrow.com.

Contact-Details: Nancy Birnbaum
Russian River PR
707-978-0610
russianriverpr@gmail.com
russianriverpr.com

Via EPR Network
More Healthcare press releases

TESTmyBRAIN opens its first center of Functional Neurology in Europe

GENEVA, 2016-Jun-8 — /EPR Healthcare News/ — TESTmyBRAIN (Switzerland) has opened its first center of Functional Neurology in Europe. This non-invasive therapy (no medication, no surgery) coming from the United States helps patients suffering from migraines, concussions, strokes, AD/HD, Parkinson disease, Alzheimer, … all disorders related to the brain and the central nervous system.

This innovative therapy combines several approaches and relies mainly over 3 decades of research on the eye-movements to diagnose and treat. Completely adopted and established in the United States, this therapy is almost unknown in Europe.

This is the reason why TESTmyBRAIN Switzerland is happy to bring the American experts to Europe to teach other doctors and to help patients differently with their pain.

SOURCE: EuropaWire

GenQual and R-Pharm collaborate to deliver predictive diagnostics for novel anti-IL-6 antibody for autoimmune diseases

Seattle, WA, San Francisco, CA and Moscow, Russia, 2016-May-25 — /EPR Healthcare News/ — R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.

The GenQual proprietary real-time PCR platform, when applied to the genes that are involved in the manifestation of several autoimmune diseases, allows us to detect and assess single nucleotide polymorphisms. Here, allelic determination is used as potential predictor of the treatment response by the novel anti-IL6 antibody, which is currently in development by R-Pharm.

GenQual Founder and CEO Jonathan Mirich said, “This partnership is exciting for GenQual as we advance in our goal to deliver predictive diagnostic tools for the treatment of autoimmune disorders. We are very excited about the possibilities in this space and are thankful to have quality partners in R-Pharm.”

R-Pharm CEO Vasily Ignatiev indicated the importance of the Autoimmune diseases as an area of the development and growth for R-Pharm, as well as the development of novel diagnostic tools aimed to increase the level of predictive response and efficiency of the upcoming treatment paradigm.

About GenQual
GenQual develops proprietary biomarker diagnostics for autoimmune and oncology indications.  Our personalized medicine products are designed to facilitate early disease detection and diagnosis, and to improve treatment approaches at the molecular level.  GenQual is a privately-held corporation based in Seattle, WA area, USA.

About R-Pharm
R-Pharm is a private Russian pharmaceutical company founded in 2001. It employs over 3,500 highly qualified specialists in 60+ branches. R-Pharm operates in Russia and CIS, USA, Germany, Japan, Turkey/MENA.

The company is involved in R&D, manufacturing (finished dosage forms, biotech and chemical APIs), marketing, sales and distribution of innovative pharmaceutical products in hospital/specialty care therapeutic areas.

R-Pharm collaborates with major international pharmaceutical companies and universities in the fields of drug discovery, development, clinical trials, manufacturing and commercialization.  The company operates several  GMP compliant manufacturing sites in Russia and Germany, research, BD/licensing and marketing affiliates in Japan, Germany, Turkey and US.

Marketed portfolio and pipeline features drugs used in oncology, hematology, autoimmune diseases, HIV, HCV, neurology, diabetes, cardiology, as well as antibiotics, contrast media and anesthesia agents.

Contact

R-Pharm
info@rpharm.ru
www.r-pharm.com/en/

 

GenQual

info@genqual.com
206.659.7825
www.genqual.com

 

Via EPR Network
More Healthcare press releases

Advanced Hair Studio Talks Preventing Premature Hair Loss

LONDON, United Kingdom, January 18, 2016 — /EPR NETWORK/ — The world’s number-one name in new-generation hair loss treatments has once again reached out to the public with important information on premature hair loss. While addressing even the more severe cases of hair thinning, falling and premature baldness that can now be effectively treated, Advanced Hair Studio continues to reinforce the value of prevention above and beyond treatment. From nutrition to overall health to lifestyle choices and more, there’s much that anyone can to do improve their chances of avoiding premature hair loss.

Premature Hair Loss

Though many instances of both female hair loss and male hair loss are impossible to prevent, an enormous proportion of cases are indeed preventable. Treatment is always an option, but Advanced Hair Studio insists that with a little proactive and positive action, premature hair loss is an unfortunate reality that could be avoided by most.

An Array of Triggers
“It is easy to realise the connection between your health and state of mind to the way your hair is behaving. Diet, strange sleep patterns, anxiety, stress, being pregnant, colds, menstrual cycles and the vitamins and pills you take to control them; all can cause hair loss. Usually someone with healthy looking hair knows how to properly care for their hair, healthy hair is also a sign that the individual is in good health. The majority of people in the UK have access, or can get access, to good nutrition; however, those who unfortunately can’t, and those with certain medical conditions, can suffer from hair loss.” – Advanced Hair Studio

In both men and women alike, three of the biggest known triggers of premature hair loss are unhealthy hair styling practices, poor dietary choices and prolonged or excessive fatigue and stress. Advanced Hair Studio warns that to ignore or overlook any such triggers is to face a dangerously elevated risk of premature hair loss, even if things appear to look and feel perfectly healthy for the time being.

The most severe problems tend to occur when these kinds of triggers are combined with one another. But as they are all either preventable or can at least to some extent be self-managed, it is never in the best interests of anyone to ignore them. At the same time, hair loss at any stage in life can also be attributed to a wide variety of underlying health conditions that may require medical attention. As such, it is better to err on the side of caution and to seek professional advice if at all concerned.

Consider a Consultation
“Premature hair loss doesn’t always happen at the same time as an emotional trauma or illness, the effects can take a while to show themselves, sometimes several months can pass before the hair begins to show signs that it has been affected. Some instances of these illnesses or emotional traumas include an operation, stress, extreme dieting, and postpartum hair loss. If you are concerned you are suffering from hair loss, a hair loss specialist can examine you and provide you a diagnosis on your current situation and any treatments available should you be suffering from hair loss.” – Advanced Hair Studio

As with most conditions related to health and wellbeing, the sooner premature hair loss is both addressed and discussed, the better. It can take time for the positive effects of any lifestyle changes to really kick in, which is why it’s always better to nip problems in the bud rather than give them time to grow and intensify. Caught early, premature hair loss need not be a detrimentally life-affecting problem.

A simple, obligation-free consultation could be all that’s needed to map out an effective approach to premature hair-loss prevention. Should treatment be required, the likelihood of an outstanding and lasting outcome accelerates exponentially when advice is sought at the earliest possible stage. Advanced Hair Studio offers free initial advice and consultation, so while there’s absolutely nothing to lose by getting in touch, there could be an extraordinary amount to gain.

About Advanced Hair Studio:
Advanced Hair is the world’s premier authority on the treatment and prevention of hair loss and baldness. Founded back in 1976 and now spanning the entire world, Advanced Hair calls upon unique and revolutionary techniques and treatments to deliver results quickly, safely and affordably. Obligation-free consultations are always available to both discuss potential hair-loss triggers and highlight available approaches to treatment.

 

advanced-hair-studio-logoContact-Details: Carl Howell, Advanced Hair Studio, 40 Fitzroy Square, London, W1T 6EY. Tel 0845 600 8899. Fax 020 3219 1088. Web https://www.advancedhair.uk. Email contactcentre@advancedhairstudio.com

Via EPR Network
More Healthcare press releases

Kaeng Raeng Launches Amazon Ambassador Program

Palo Alto, CA, June 27, 2015 — /EPR HEALTHCARE NEWS/ — Kaeng Raeng, a leading creator of natural dietary supplements and cosmetics, best known for it’s 3-day Detox Cleanse program, has announced the launch of a new Amazon Ambassador program.

Amazon’s community guidelines allow for brands to provide free product or samples of products to individuals in exchange for an expectation of an Amazon review. Kaeng Raeng will accept applicants via their website to sample product offerings in expectation of ambassadors leaving Amazon reviews, which are not required to be positive-just honest.

Those interested in becoming Amazon Ambassadors can apply here:http://kaengraeng.com/index.php/feedback, to become part of this exciting new program.

About Kaeng Raeng
Based in Palo Alto, California, Kaeng Raeng is a leading creator of natural dietary supplements and cosmetics. Founded by certified personal trainer and Stanford alumna Lindsay Reinsmith, Kaeng Raeng is a delicious, convenient, and affordable cleanse program. For more information, visit www.kaengraeng.com or join the brand on Facebook at Facebook.com/kaengraeng.

Kaeng Raeng – Be Healthy. Be Strong.

Contact-Details:
Contact: Kelly Bronson
Kaeng Raeng Director of Marketing
kelly@kaengraeng.com

 

Via EPR Network
More Healthcare press releases

HTN propone EASY BLOOD PRESSURE, una nuova e facile soluzione per il monitoraggio domiciliare della #pressionearteriosa

Brescia, Italia, May 19, 2015 — /EPR NETWORK/ — Secondo la #SIIA (Società Italiana dell’Ipertensione Arteriosa), in Italia


• il 31% delle donne ed il 33% degli uomini soffre d’ipertensione arteriosa*
• il 14% delle donne ed il 19% degli uomini “sani” sono in una condizione di rischio**
• solo il 35% degli ipertesi trattati ha valori di pressione arteriosa normalizzati”***
• l’obbiettivo è portare, entro il 2015, il 70% della popolazione degli ipertesi alla normalizzazione dei valori di pressione arteriosa.

* Ipertesi: sono i pazienti con pressione arteriosa uguale o superiore a 140/90 mmHg..
** Condizione di rischio: quando il valore della pressione sistolica è compreso fra 140 e 160 mmHg e quello della diastolica è compreso fra 90 e 95 mmHg.
*** Secondo le Linee Guida Europee 2013 i valori di norma sono quelli inferiori a 130/85..

Le Linee Guida 2013 della Società Europea dell’#Ipertensione sottolineano che i valori di pressione arteriosa rilevati al domicilio hanno un significato prognostico maggiormente predittivo di accidenti cardiovascolari rispetto ai valori rilevati in ambulatorio.
#HTN Easy Blood Pressure è l’abbonamento annuale per il monitoraggio della pressione arteriosa, in modo semplice ed efficace.

Il servizio si basa sull’utilizzo, in alternativa, di due device per la rilevazione dei valori della pressione arteriosa:
• iHealth BP5, a trasmissione via Bluetooth
• A&D UA-767NFC, a trasmissione via NFC
L’abbonato è in grado di rilevare quante misure desidera e tutte saranno trasmesse, attraverso uno smartphone, al proprio Personal Health Record, sempre accessibile in modo sicuro, attraverso la piattaforma software proprietaria #SmartTelemedicine.
Ogni tre mesi, oppure a sua richiesta, riceverà un referto sui valori registrati.

In sintesi, l’offerta prevede:
• quattro prestazioni di refertazione specialistica dei valori pressori all’anno
• una chiamata a personale sanitario HTN all’anno
• fino a 4 Personal Health Record sulla piattaforma software SmartTelemedicine
• il comodato d’uso gratuito dell’apparecchiatura #iHealth BP5 ovvero A&D UA-767NFC
Ulteriori prestazioni di refertazione e/o teleconsulto possono essere richieste in qualsiasi momento.

Per maggiori informazioni: http://www.e-htn.it/it/contatti/

Contact-Details: Dr. Fulvio Glisenti – Presidente, Health Telematic Network s.r.l.
info@e-htn.it

Via EPR Network
More Healthcare press releases

A Bold Move: 79-year old champion bodybuilder competes against 40-, 50-, 60-year olds!

Amador County, CA, May 08, 2015 — /EPR HEALTHCARE NEWS/ — A career spanning nearly 50 years isn’t over yet for Amador County veteran bodybuilder and one of the original Mr. Venice Beach competitors, Arthur Peacock. Peacock, who is turning 80 this year, takes the stage with 40-, 50-, and 60-year olds this Saturday, May 9 at the Contra Costa Bodybuilding Championship, to be held in the Chabot College Performing Arts Theatre.

“There is no doubt that this is a career turning point for me. It’s what I’ve been training for my entire life, but especially the last three years. I’ll have 60-seconds to prove myself—my physique and my poses—with competitors between 40 and 69. That’s potentially almost 40 years younger than me.”

Peacock chose to compete in three classes for a couple of reasons—no 70s bracket existed, and he has every intention of continuing his legacy to inspire others who want to follow their bodybuilding dreams.

“I want people to see me and say, ‘I can do that. Look at that guy up there at 80.’ I want to inspire to the end; I’ve done it all my life. I’ve had world champions come up to me and say, ‘I remember when you stopped and spoke to me as a teenager, and now, 20 years later, I’m the number one guy. Thank you.’”

It was in 1965, as an already athletic young man in his early 30s, an avid swimmer, surfer cyclist, and hiker, that Peacock went as a spectator with his friends to his first bodybuilding competition. “I knew I wanted to do that—that I could do that.” And that he did, taking home his first trophy in the 1968 Mr. Venice Beach competition, which gave rise to a half-century career with more than 50 major titles earned.

MORE INFORMATION:
www.arthurpeacock.com

For interviews requests, speaking engagements or photo shoot requests, go to: larisa@curtismode.com

CONTACT:
Larisa Curtis
209.217.6452

Via EPR Network
More Healthcare press releases

NBC casting new TV series S.T.R.O.N.G in Austin!

BURBANK, CA, May 08, 2015 — /EPR HEALTHCARE NEWS/ — From the Network that brought you THE VOICE & AMERICAN NINJA WARRIOR and from the creator of THE BIGGEST LOSER, comes a new transformational competition series.

NBC’s newest fitness-focused reality series, S.T.R.O.N.G. is casting nationwide, looking for contestants that are ready to take on the challenge of becoming the strongest version of themselves.

12 contestants and 12 of the world’s best fitness trainers will pair up, compete and train together in this physical and mental competition. One team will take home the LARGE CASH PRIZE, but all teams will have a transformational experience that will not only change their bodies and lives, but inspire America along the way.

DO YOU WANT TO GET STRONG?

Are you ready to undergo a mind-blowing physical transformation? Are you ready to stop making excuses and start making changes? Looking for people from all different walks of life with a range of different stories and reasons they haven’t taken that next step in life, but are ready! If you’re trying to overcome a personal struggle and you want to become your best self, APPLY TODAY – CASTING NATIONWIDE!

WWW.NBCStrongcasting.com

Come and meet the S.T.R.O.N.G. Casting Team in person!

Open Calls will be held in the following cities:

AUSTIN, TX
Saturday May 16th, 2015
Aloft
11601 Domain Dr.
Austin, Tx 78758
11am-4pm

CHICAGO, IL
Saturday May 16th, 2015
Lucky Strike
322 E. Illinois Street
Chicago , IL 60611
11am-4pm

NEW YORK, NY
Saturday May 30th, 2015
NBC Experience/Rockefeller Center
30 Rockefeller Plaza
New York, NY 10112
11am-4pm

LOS ANGELES, CA
Saturday June 6th, 2015
Location:TBD
12pm-5pm

Press Contact:
Cara Chandler
Casting Producer
818.569.4052 ext 6916
cara@castingduo.com

Via EPR Network
More Healthcare press releases

A New natural treatment for female infertility caused by tubal blockage and hydrosalpinx helps women conceive without painful surgery

Tubal blockage caused by inflammation, and hydrosalpinx, which are commonly used to be treated with surgery, such as laparoscopy, now can be cured with a new natural treatment – Fuyan pill – a herbal medicine invented by Dr. Lee who comes from Wuhan Dr. lee’s TCM clinic. It gives the hope for the female infertility to be conceived successfully.

Wuhan, CHINA, May 04, 2015 — /EPR HEALTHCARE NEWS/ — The Fuyan pill, based on ancient Chinese formulas for gynecological inflammations, which lasts for over 5000 years, is made from natural pure herbs without any chemical composition. According to the data from Wuhan Dr. Lee’s TCM Clinic, this natural herbal formula has cured hundreds of thousands women infertility who had suffered from tubal blockage led by inflammation, hydrosalpinx and their complications.

The inventor of this herbal medicine, Dr. Lee introduces: “This herbal medicine can cure inflammatory tubal blockage and hydropsalpinx without any other unpleasant procedures.” “Even for those had tried IVF to conceive unsuccessfully. Fuyan Pill also works on some of them when they try it as their last shot. According to our clinical cases, these diseases are commonly cured after three to four months medication. ” Dr. Lee says

Ada who had suffered from inflammatory tubal blockage for more than 3 years told us. “I had never been imaging that Fuyan Pill could work so fast that I got pregnant in third month medication. Well to be frank, taking the pills are not very pleasant experience, but doing these for 4 months is really worth my effort. I have been under a lot of pressure not being able to conceive, and I sometimes have even doubted the efficiency of this herb, because I feel nothing during the medication. However everything has changed after I got my ultrasound report after I finish 3 months pills. Dr. Lee has suggested me to take one more months pills after that in case it recurs and I have done as she’s recommended. The pill has made a huge difference and I am so grateful for what Dr. Lee has done.”

Chinese medicine owns outstanding sterilizing power to treat tubal blockage, especially, has special effects on hydrosalpinx. The pill can effectively cure these kinds of diseases without any side effects. It also contains prescription to clear away heat and toxic material, promote blood circulation, dissolve stasis, unblock the fallopian tubes and drive away the hydrops completely, which help to retrieve fallopian tube movements and clear the tube for the fertilization of eggs. Thus it could help patients conceive naturally without surgery. Patients could try pregnant after taking the medicine for 3 to 4 months.

Dr. Lee says, “Fuyan Pill has been widely used in our own clinic in China, the clinic states also show that it has been effectively cured women with inflammatory tube blockage and hydrosalpinx who don’t want to undergo surgery. It also has no postoperative problems, this really attractive for many women. So there are increasing number of women have benefitted from this magical medicine recent years. We really hope it could also help women infertility caused by inflammatory tubal blockage and hydrosalpinx from all over the world.”

About Dr. Lee Xiaoping and the herbal medicine:
Dr. Lee Xiaoping graduated from Hubei College of Traditional Chinese Medicine, China. She qualified as an herbalist 30 years ago and is a highly experienced medical professional. She specializes in the field of male and female reproductive and urinary system diseases. She has devoted 30 years to her clinic and worked on the formula of Fuyan Pill for years. The medicine has proven to be effective on treating tubal conditions. The formula is patented by SIPO (State Intellectual Property Office of the P.R.C) with the application number 201110031968.

For more details about DR. Lee and Wuhan Dr. Lee’s TCM Clinic, please kindly view http://www.drleetcmclinic.com/

Contact-Details:
Wuhan Dr. Lee
Telephone: +86-027-87105085
Email: herbalistlee@yahoo.com, wuhandrlee@hotmail.com
Website: http://global.fuyanpills.com/index.html

Via EPR Network
More Healthcare press releases